title: [Administration of dicarbamin in the course of taxotere-assisted chemotherapy].
authors.forename: I A
authors.initials: IA
authors.lastname: Koroleva
authors.forename: A S
authors.initials: AS
authors.lastname: Mochalova
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002208:Caproates; D000077143:Docetaxel; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D007970:Leukopenia / Q000139:chemically induced / Q000517:prevention & control; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced / Q000517:prevention & control; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D020011:Protective Agents / Q000627:therapeutic use*; D043823:Taxoids / Q000008:administration & dosage / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D002208:Caproates; D007093:Imidazoles; D020011:Protective Agents; D043823:Taxoids; D000077143:Docetaxel; C539419:pentanedioic acid imidazolyl ethanamide